Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Avapritinib(Ayvakit)

It is indicated for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) harboring PDGFRA exon 18 mutations, advanced systemic mas···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：55
Baricitinib(Olumiant)

It is indicated for the treatment of various immune-related diseases in adults and children aged 2 years and older, including rheumatoid arthritis, atopic dermatitis, alopecia area···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：39
Biktarvy(bictegravir/emtricitabine/tenofovir alafenamide)

It is a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult patients and pediatric patients with a body weight of at least 14 kilog···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：76
Bosentan(Tracleer)

It is indicated for the treatment of pulmonary arterial hypertension (PAH) in adults and children aged 3 years and older, which can improve exercise tolerance and delay clinical de···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：42
Cabergoline(Dostinex)

It is indicated for the treatment of hyperprolactinemia in adults, including conditions caused by idiopathic factors or pituitary adenomas.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：48
Cobimetinib(Cotellic)

This product is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations (in combination with vemurafenib), as···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：104
Dasatinib(Sprycel)

For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia in adults and children 1 year of age and older.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：50
Elafibranor(Iqirvo)

It is indicated for the treatment of adult patients with primary biliary cholangitis who have an inadequate response to or intolerance of ursodeoxycholic acid.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：59
Encorafenib(Braftovi)

It is indicated for the treatment of unresectable or metastatic melanoma, colorectal cancer, and non-small cell lung cancer with BRAF V600E or V600K mutations, and must be used in ···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：69
Epclusa(Sofosbuvir and Velpatasvir Tablets‌)

It is indicated for the treatment of adult and pediatric patients aged 3 years and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection. This includes ···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：43
Erlotinib(Tarceva)

It is mainly indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring specific gene mutations (EGFR exon 19 deletion or exon 21 L858R substitution mut···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：42
Everolimus(Afinitor)

Indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer; neuroendocrine tumors of pancreatic, gastrointestinal, and pulmonary origin; advance···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：45

home page previous 48 48/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More